High-density lipoproteins neutralize C-reactive protein proinflammatory activity

被引:139
作者
Wadham, C
Albanese, N
Roberts, J
Wang, LJ
Bagley, CJ
Gamble, JR
Rye, KA
Barter, PJ
Vadas, MA
Xia, P
机构
[1] Inst Med & Vet Sci, Div Human Immunol, Hanson Inst, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Adelaide, SA, Australia
[3] Heart Res Inst, Lipid Res Grp, Camperdown, NSW, Australia
关键词
lipoproteins; protein; inflammation; atherosclerosis;
D O I
10.1161/01.CIR.0000127419.45975.26
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-C-reactive protein (CRP), a well-recognized marker of atherosclerosis, has recently been suggested to have a direct proinflammatory effect. The constitutive expression of low levels of CRP in normal plasma suggests the likelihood that a natural factor exists to neutralize the effect of CRP. This factor(s) has not yet been identified. Method and Results - The proinflammatory effect of CRP was measured by the induction of inflammatory adhesion molecules in human umbilical vein endothelial cells (HUVECs). We show that CRP significantly induced upregulation of adhesion molecules in both protein and mRNA levels. The CRP-induced expression of these inflammatory adhesion molecules was completely suppressed when the cells were preincubated with a physiological concentration ( 1 mg/mL apolipoprotein A-I) of HDLs derived from human plasma (native HDL) or reconstituted HDL (rHDL) at a very low concentration (0.01 mg/mL apolipoprotein A-I). A novel mechanism of HDL inhibition is likely to operate, because ( 1) rHDL was 100 times more potent than native HDL, ( 2) preincubation with HDL and its sustained presence were obligatory, and ( 3) oxidized 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine was the fundamental active component. Conclusions - The CRP-induced upregulation of inflammatory adhesion molecules in HUVECs was completely prevented by HDL via their oxidized phospholipid components.
引用
收藏
页码:2116 / 2122
页数:7
相关论文
共 28 条
[11]   STRUCTURE AND FUNCTION OF THE PENTRAXINS [J].
GEWURZ, H ;
ZHANG, XH ;
LINT, TF .
CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (01) :54-64
[12]  
Gräbner R, 2000, CYTOMETRY, V40, P238, DOI 10.1002/1097-0320(20000701)40:3<238::AID-CYTO9>3.0.CO
[13]  
2-3
[14]  
JONAS A, 1986, METHOD ENZYMOL, V128, P553
[15]   Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils [J].
Leitinger, N ;
Tyner, TR ;
Oslund, L ;
Rizza, C ;
Subbanagounder, G ;
Lee, H ;
Shih, PT ;
Mackman, N ;
Tigyi, G ;
Territo, MC ;
Berliner, JA ;
Vora, DK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (21) :12010-12015
[16]  
MATZ CE, 1982, J BIOL CHEM, V257, P4535
[17]   MEASUREMENT OF MESSENGER-RNA FOR E-SELECTIN, VCAM-1 AND ICAM-1 BY REVERSE TRANSCRIPTION AND THE POLYMERASE CHAIN-REACTION [J].
MEAGHER, L ;
MAHIOUZ, D ;
SUGARS, K ;
BURROWS, N ;
NORRIS, P ;
YARWOOD, H ;
BECKERANDRE, M ;
HASKARD, DO .
JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 175 (02) :237-246
[18]   C-reactive protein and coronary heart disease in western Turkey [J].
Onat, A ;
Sansoy, V ;
Yildirim, B ;
Keles, I ;
Uysal, Ö ;
Hergenç, G .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (06) :601-607
[19]  
Pan LF, 1998, CLIN EXP IMMUNOL, V112, P533
[20]  
Pasceri V, 2000, CIRCULATION, V102, P2165